“ Aliskiren mitigated the increases in plasma ADMA in SHRs.”
“Early aliskiren treatment mitigates increases in ADMA , restores l-Arg-to-ADMA ratios, enhances neuronal NOS-α, prevents decreased nNOS-β levels in the kidney-which might restore NO bioavailability and contribute to the decrease of blood pressure in young SHRs.”
“ Renal ADMA levels were lower in SHRs that received high-dose aliskiren versus SHRs.”